Login / Signup

POLARIS: efficacy and safety of a vaginal medical device in recurrent bacterial vaginosis-a multicenter, open-label, non-controlled, study with 10 months of follow-up.

Filippo MurinaPaolo InghiramiMarius BirișDaniela SîrbuDionisio Franco BarattiniLuca Ivan ArdolinoMario MangrellaElena CasolatiSerban Marius RoșuCiprian Crișan
Published in: The Journal of international medical research (2024)
The use of PLGG vaginal ovules in the treatment of BV reduces the rate of recurrence and apparently produces a positive effect on the vaginal microbiota.
Keyphrases
  • open label
  • healthcare
  • clinical trial
  • lps induced
  • randomized controlled trial
  • phase ii
  • study protocol
  • cross sectional
  • combination therapy
  • double blind
  • phase iii
  • inflammatory response
  • smoking cessation